. Collagen contractility and Gleason grade and patient age. Collagen contractility of CAF derived from patients of different Gleason score was examined, however there was no statistically significant difference in contractility when measured as a group. Similarly, there was no correlation between patient age and CAF contractility when compared as a group.
CAF population AGE
Gleason Score Excluded from evaluation: outlier tumour of V = 4.4 mL in the control group of the current study. Figure S1 . Histology of CAF/BPH1 tumours after treatments with HSP90 inhibitors in vivo.
To examine effects upon cell proliferation, tissue sections of CAF/BPH1 tumours were stained for the proliferation marker Ki67 (labelled IHC). Images were analysed via software to quantify Ki67 expression in nuclei by pseudocoloring positive nuclei followed by counting (labelled Analysis). Ki67-positive nuclei were stained dark brown for IHC and presented in false colour beige in the analysis images. The top rows shows IHC for tumours treated with dipalmitoyl-radicicol, while the lower row shows tumours treated with 17-DMAG. Figure S4 . Effects of Dorsomorphin upon CAF contractility. CAF contractility was assessed in the presence of 0, 5 or 10μM Dorsomorphin, which showed a significant inhibition of CAF contractility. Dorsomorphin is in inhibitor of BMP signaling, however, other BMP inhibitors had no effect upon CAF contractility, and we speculate that it was an off target effect of dorsomorphin upon HSP90 which led to the effects upon contractility. Asterisks denote the level of significance: * for p < 0.05, ** for p < 0.01 and *** for p < 0.001.
